Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice by Nicola Ivan Lorè et al.
RESEARCH ARTICLE Open Access
Host genetic diversity influences the severity
of Pseudomonas aeruginosa pneumonia in
the Collaborative Cross mice
Nicola Ivan Lorè1*, Fuad A Iraqi2† and Alessandra Bragonzi1*†
Abstract
Background: Pseudomonas aeruginosa is one of the top three causes of opportunistic infections in humans.
Patients with a compromised immune system, due to immunosuppressive therapies or underlying diseases such as
cancer, AIDS or the hereditary disease cystic fibrosis, are at risk of developing P. aeruginosa infection. However,
clinical evidence indicates extremely variable outcomes of P. aeruginosa infections in individuals at risk, suggesting
that host multi-complex genetic traits may influence the severity of this opportunistic infection. Here, we have used
an innovative experimental model to dissect whether host genetic background, such as those found in the outbred
population, could influence the risk of morbidity and mortality to P. aeruginosa pneumonia.
Results: A highly genetically-diverse mouse resource population, Collaborative Cross (CC) mice, was infected with a
clinical strain of P. aeruginosa and subsequently monitored for mortality, mean survival time, and morbidity, change
in body weight for seven days post infection. Disease phenotypes ranged from complete resistance and recovery of
body weight to lethal disease. Initial variables, including body weight, age and gender, have limited influence on P.
aeruginosa outcome, emphasizing the role of host genetic background in defining the risk of morbidity and
mortality. When broad-sense heritability of phenotypic traits was evaluated, it confirmed the influence of genetic
profile rather than environmental factors among the CC lines during P. aeruginosa infection.
Conclusion: This innovative model system can potentially reproduce the variables responses of disease severity
observed in humans during P. aeruginosa pneumonia. Our results demonstrated that a widely-marked differential
response to P. aeruginosa airway infection in term of morbidity and mortality, is mainly affected by host genetic
factors, as multiple genetic loci or polymorphic variations.
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Background
Genotype is an important determinant factor in human host
susceptibility to major diseases, including infections [1].
There is increasing evidence that some inter-population
and inter-individual differences in the attack rate and prog-
nosis of specific infectious organisms are due to inherited
genetic variants and, for the most part, to multicomplex
genetic traits (polygenetic traits) [2]. These findings are
changing our view of infections as we can now assume that
pathogens are not the sole determinants of the correspond-
ing infectious diseases. Host response is influenced by the
complex combinations and variations of genes, and this af-
fects the outcome of the infectious disease. An efficient ex-
perimental method to dissect complex genetic traits still
needs to be established. Recently, a new community
resource - Collaborative Cross (CC) mice - has been
implemented as a common platform for mammalian
complex genetic traits in an attempt to overcome the limita-
tion of existing resources [3, 4]. The CC is a murine
reference population with high genetic diversity,
constructed using a randomized breeding design that
systematically outcrosses eight founder strains, followed by
inbreeding to obtain new recombinant inbred strains. Five
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of the eight founders are common laboratory strains (A/J,
C57BL/6 J, 129S1/SvImJ, NOD/LtJ, NZO/HiLtJ), and three
are wild-derived strains (CAST/EiJ, PWK/PhJ, and WSB/
EiJ) [5]. The CC has been genotyped and showed more
recombination and genetic variation compared to the
other reference panels [6]. The genomes of the CC
founder strains (http://www.sanger.ac.uk/resources/
mouse/genomes/) and CC lines strains (http://csbio.
unc.edu/CCstatus/index.py) (http://mus.well.ox.ac.uk/
CC/) have been genotyped or sequenced, so it is
possible to reconstruct the haplotypes of each CC line
as a fixed mosaic of the founder chromosomes [6, 7].
Hallmarks of CC lines include high mapping resolution
and sample sizes that are sufficient to drive phenotypic
diversity in almost any trait of interest.
This paper reports the use of CC mice as an innovative
forward genetic approach to determine whether and to
what extent host genetic background, influences the
variability of P. aeruginosa acute respiratory infection.
P. aeruginosa retains a prominent position as a major
worldwide cause of morbidity and mortality in a wide range
of patients including those with a compromised immune
system from immunosuppressive therapies or underlying
diseases such as cancer, AIDS or the hereditary disease,
cystic fibrosis (CF) [8–10]. Clinical evidence indicates that
the outcome of P. aeruginosa infections may be extremely
variable among individuals at risk, suggesting that host
multicomplex genetic traits may influence the severity of
this opportunistic infection. Genetic mapping in the human
population has been performed, but partially achieved
significance in the genome-wide association study [11].
Studies from CF twins and sibs have suggested that suscep-
tibility to chronic infection with P. aeruginosa is affected by
genetic inheritance determinants, whereas initial infection
is minimally influenced by genetic modifiers [12]. However,
the size of the cohorts, the strong but often unknown
environmental influences, poor diagnosis and lack of
repeatability are bottlenecks in human studies that high-
light the need for novel resources [13–15]. Mouse inbred
strains are the starting point from which to explore causal
genotype-phenotype relationships and identify gene map-
ping however they do not offer a strong tool to identify
and study polymorphic variations, that are hallmarks of
the human population [16, 17]. The number of classical
inbred strains is relatively small. This limits genetic and
phenotypic diversity and the value of Quantitative Traits
Loci (QTL) detection. Thus, innovative experimental ani-
mal models are absolutely essential to complement the
human studies [18]. Using CC mice, it is possible to deter-
mine genotype variation associated to disease phenotypic
traits (e.g., using merge analysis) [6, 7]. Power and reso-
lution mapping of CC mice was recently completed
for host susceptibility to Aspergillus fumigatus [7], in-
fluenza A [19, 20], Klebsiella pneumoniae [21] and
reported for the first time in this paper as proof-of-
concept for new studies to map QTL associated with
the opportunistic bacteria P. aeruginosa.
Results
Host genetic background influences the severity of
P. aeruginosa pneumonia
CC lines, infected with P. aeruginosa, showed a wide-range
of Survival time (ST) ranging from complete resistance
(100 % survival after seven days post-infection) to lethal
disease (100 % death after 1.5 days), while A/J mice showed
an intermediate phenotype (30 % of mortality rate after
7 days post-infection) (Fig. 1a, Additional files 1 and 2).
Similarly, CC lines had a wide variation in body weight
(BW) response to P. aeruginosa infection: ranging from a
23 % decrease in BW after three days to those showing an
almost total recovery of change in BW after five days
(Fig. 1b). A/J mice lost 16 % of their change in BW after
three days but they did not recover completely after seven
days. At day 7 post-infection, bacterial cells were not
recovered in the organs (blood, liver and lung) of surviv-
ing mice (data not shown), indicating that bacterial clear-
ance is independent from differences in morbidity as
assessed by recovery of body weight. These data confirm
that different traits of the CC mice resource population
express a wide response to P. aeruginosa infection, sug-
gesting the key role of genetic variance on the severity of
the clinical outcome.
Segregation analysis of disease phenotypic traits
Phenotypic traits for segregation analysis of mean survival
time (MST) and change in body weight at day one (CBW1)
after P. aeruginosa airway infection were selected based on
previous studies with commercial inbred strains [17, 22].
Thus, segregation analysis of the phenotypic trait distribu-
tions highlights the different responses among CC lines.
Figure 2 shows MST and CBW1 of the CC lines, arranged
by increasing order of magnitude. Based on the statistical
significance using Bonferroni’s Multiple Comparison Tests
(reported in Additional file 3), CC lines were arranged by a
similar variation degree of recorded traits in three groups
(Fig. 2). Thus, in the high tail of MST, four CC lines
(IL2156, IL521, IL2689, IL3438) were ranked with the
highest MST value (MST: 5.3/7) while in the low tail, five
CC lines (IL711, IL1061, IL188, IL2126, IL1912) showed
the lowest MST values (MST: 1.41/1.48) (Fig. 2a). An inter-
mediate group of eight murine lines (IL4052, IL611, IL72,
IL111, IL3912, IL4457, IL4141, IL519) showed a medium
MST value (MST: 1.6/4.5). Statistical analysis of CBW1
highlights a two-fold difference between the highest
(IL4141, IL519, IL188; CBW1: −7.22 %/−9.33 %) and
the lowest CC line groups (IL72, IL521, IL4457;
CBW1: −3.16 %/−4.34 %) (Fig. 2b). An intermediate
group of eleven murine lines (IL4052, IL2689, IL711, IL611,
Lorè et al. BMC Genetics  (2015) 16:106 Page 2 of 6
IL3912, IL3438, IL2156, IL2126, IL1061, IL1912, IL111;
CBW1: −4.70 %/−6.80 %) was also recorded. Overall our
data show a wide range of responses to P. aeruginosa infec-
tion, potentially caused by allelic segregations from the
eight founders strains.
Effect of initial body weight, age and gender on disease
phenotypes
The effects of initial body weight or age on ST, CBW1 were
tested across 17 CC lines and A/J mice; they were found
not to be significant by Spearman‘s Correlation (Table 1A).
Similarly, gender effect on ST and CBW1 was not signifi-
cantly correlated when the whole murine population was
considered. Within individual CC lines no significant gen-
der effect on disease phenotypes was observed among male
and female mice (Table 1B), although a limited number of
animals was consider. All together these results, emphasize
the key role of genetic determinants in the severity and in
the outcome of P. aeruginosa airway infections using this
diverse murine population.
Heritability of disease phenotypes during P. aeruginosa
pneumonia
To test if the traits variations within the infected CC
murine population were due to genetic factors, we esti-
mated heritability as described [23, 24]. Broad-sense
heritability (H2) was calculated for all the CC lines for
which MST and CBW1 were recorded (Fig. 2c). Esti-
mated H2 was 0.54 and 0.28 for MST and CBW1,
respectively. Thus, on observation of the CC lines during
P. aeruginosa infection, there is a clear host response
that is affected by the genetic components as opposed to
the purely environmental factors.
Fig 1 Disease phenotypes in CC mice during P. aeruginosa acute respiratory infection. 17 CC lines and A/J mice of 8–14 weeks old (between 3–7
mice per Line), were inoculated with a 1×106 cfu dose of the P. aeruginosa clinical isolate AA2, and monitored for survival time ST (a) and body
weight BW (b) for a period of 7 days after infection
Fig 2 Evaluation of MST, CBW1 and H2 of CC lines after P. aeruginosa airway infection. The CC mice resource population had a strong wide-
response to P. aeruginosa airway infection in the MST (a) and CBW1 traits (b). MST and CBW1 of CC lines are arranged in increasing order of mean
magnitude. Based on Bonferroni's Multiple Comparison Tests (BMCT) (Additional file 3: Table S3) three distinct groups have been identified among
17 CC strains infected with P. aeruginosa and are indicated as scales of grey. Estimates of broad sense H2 (c) have been evaluated for MST and
CBW1, as previously described [23]
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Discussion
Several studies highlight how host response to infection
may be strongly influenced by the cumulative effect and
interactions of multiple genetic loci and by a complex set of
other factors (e.g. the environment, the bacterial strain and
origin, age and gender) [1, 13, 25]. Among the most rele-
vant infectious diseases that affect humans, P. aeruginosa
shows a wide variation in the clinical outcome in individ-
uals at risk [8–10], indicating that the host-response may
contribute to the variation of morbidity and mortality.
However, predictive experimental animal models to dissect
complex genetic traits, such as multiple genetic loci, that
can influence the outcome of P. aeruginosa respiratory
infection, remain to be established. To date, a poor pheno-
type/genotype correlation in human studies and the lack of
a fully faithful mouse model have limited scientific advance-
ments in the field [13–15]. To meet the current challenge
of complex trait analysis, we used CC mice to evaluate the
contribution of the host to P. aeruginosa pathogenicity.
First, based on phenotypic diversity of human response to
infection, we defined two end-points (ST and BW) that
may ultimately have clinical relevance in term of morbidity
and mortality. Based on previous studies with commercial
inbred strains [17, 22], MST and CBW1 were selected as
phenotypic disease traits to perform segregation analysis.
Our approach generated wide-marked range of phenotypic
differences in terms of MST and CBW1 during P. aerugi-
nosa pneumonia, although a limited number of lines were
considered. On the other, future experiments will define
detailed phenotypic traits, such as bacterial load, inflamma-
tory cytokines or cellular recruitment into the lung.
Next, initial variables - including body weight, age and
gender - have limited influence on P. aeruginosa outcome,
emphasizing the key role of genetic determinants in the
disease severity in our infectious model system. In addition,
the high value of the broad-sense heritability of the two
recorded disease phenotypic traits support our suggestion
that host genotype is an important determinant factor in
the disease’s severity. A similar approach was developed
using Diversity Outbred mice to model Staphylococcus
aureus and influenza Virus pneumonia [26]. Interestingly,
they demonstrated that initial body weight correlated with
viral burden, including co-infected mice, but not with
S. aureus bacterial load. These suggest that the correlation
of initial body weight and infectious graveness is modulated
by the specific host-pathogen interplay. Both host genetic
background and type of pathogen may have a key role in
determining morbidity.
Of relevance, the power of CC population as model
system relies also in the fact that all potential co-variables,
that may influence phenotypic traits, are taken into account
in the statistical analysis. Thus for future mapping of key
genetic loci/genes, by using CC population and model of
airway infection, we can track the influence of confounding
effects that are bottlenecks in genetic mapping in the hu-
man population.
Conclusions
Exploring CC mouse population together with a model
of respiratory infection, our results demonstrates that
P. aeruginosa opportunistic infection has wide range
of disease phenotypes affected by multiple host genetic
factors, such as multiple genetic loci or polymorphic
variations. Future mapping of key genetic loci/genes
involved in the P. aeruginosa infection will be carried out
with the use of additional CC lines and further traits of dis-
ease phenotypes will be assessed. This innovative approach,
Table 1 Analysis of initial body weight, age and gender on
disease phenotypes
A Survival Time (n = 92) Change in BW day 1 (n = 92)
Initial body weight r = 0.192 P > 0.05 r = 0.010 P > 0.05
Week’s old r = 0.099 P > 0.05 r = 0.173 P > 0.05




Mean SEM n Mean SEM n P value
A/J 1.83 0.60 3 4.67 1.06 6 P > 0.05
IL 4052 1.83 0.33 3 1.50 0.00 3 P > 0.05
IL 3438 7.00 0.00 3 7.00 0.00 3 P > 0.05
IL 2156 7.00 0.00 3 3.67 1.69 3 P > 0.05
IL 711 1.50 0.00 2 1.30 0.12 5 P > 0.05
IL 2126 1.50 0.00 4 1.50 0.00 2 P > 0.05
IL 4141 4.25 2.75 2 4.50 1.46 4 P > 0.05
IL 4457 5.17 1.36 3 2.50 0.00 2 P > 0.05
IL 1912 1.17 0.17 3 2.00 0.50 3 P > 0.05
% Change in body weight day 1
Male Female ANOVA
Mean SEM n Mean SEM n P value
A/J −10.53 5.90 2 −11.30 1.11 5 P > 0.05
IL 4052 −3.05 0.94 3 −6.37 0.91 3 P > 0.05
IL 3438 −6.52 0.79 3 −4.28 0.47 3 P > 0.05
IL 2156 −5.69 1.75 3 −5.18 1.41 3 P > 0.05
IL 711 −5.13 1.30 2 −5.10 1.23 2 P > 0.05
IL 2126 −6.18 1.19 4 −5.15 0.49 2 P > 0.05
IL 4141 −8.45 1.27 2 −6.62 0.43 4 P > 0.05
IL 4457 −3.76 1.41 3 −5.23 2.03 2 P > 0.05
IL 1912 −6.36 0.00 1 −6.29 0.59 3 P > 0.05
Overall Spearman‘s correlation (r correlation coefficients and P value) between
all the initial parameters (initial BW, week’s old and gender) of CC lines and
recorded traits (ST: n = 92, CBW1: n = 92) to determine potential influence (A).
Two-way ANOVA’s comparison across eight selected CC lines and A/J
commercial inbred line to evaluate gender influence on recorded traits
(MST and CWB1) (B)
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based on the concept of forward genetics, will provide new
insight into the key molecular processes that control host/
pathogen interactions in respiratory disease, and should




All experimental mice and protocols were approved by
the Institutional Animal Care and Use Committee of Tel
Aviv University (TAU) (approval number: M-13-079). P.
aeruginosa clinical isolate AA2 was obtained from CF pa-
tient attending the Medizinische Hochschule of Hannover,
Germany and described previously [17, 22, 27]. Research
on the bacterial isolates from the individual with CF has
been approved by the responsible physician at the CF
center at Hannover Medical School, Germany. Patient
gave informed consent before the sample collection.
Approval for storing of biological materials was obtained
by the Hannover Medical School, Germany.
Collaborative cross and inbred lines
A total of 92 (50 Males, 42 Females) mice (8 to 14-week
old) from 17 different CC mouse lines (average 3–7 mice
per line) were provided by the Small Animal Facility at
Sackler Faculty of Medicine, Tel Aviv University (TAU).
The lines were at inbreeding generations F20-F39, mini-
mum 90 % homozygosity. Full details of the development
of these CC lines are given in Welsh et al. [3, 28]. In
addition to the CC mice, commercially inbred lines, A/J
mice were used as internal control and were was purchased
from Jackson Laboratory. The infection challenge was
carried out at the BSL-2 laboratory at TAU. Mice were
housed on hardwood chip bedding in open-top cages at the
animal facility and were given tap water and rodent chow
ad libitum.
After P. aeruginosa infection, mice were monitored
twice per day for the parameters vocalisation, piloerection,
attitude, locomotion, breathing, curiosity, nasal secretion,
grooming and dehydration. Mice that lost >25 % body
weight and had evidence of severe clinical disease, such as
scruffy coat, inactivity, loss of appetite, poor locomotion,
or painful posture, were sacrificed before the termination
of the experiments with an overdose of carbon dioxide.
P. aeruginosa strain and mouse model of acute
respiratory infection
Prior to the animal experiments, P. aeruginosa AA2 clinical
strain was grown in Trypticase Soy Broth (TSB) to reach
the exponential phase at 37 °C [22, 27]. The mice were
anesthetized and infected by intratracheal injection with a
106 colony forming unit (cfu) implanted into the lung via
the cannula, with all lobes inoculated as described [22]. ST
and BW of mice were monitored daily over one week; then
the surviving mice were euthanized and tested for cfu in
blood, liver and lung.
Disease phenotypic traits and segregation analysis
ST and BW of mice were considered as disease phenotypic
traits for mortality and morbidity of P. aeruginosa pneumo-
nia. In particular, MST and CBW1 were selected for segre-
gation analysis, based on previous studies with commercial
inbred strains [17, 22]. At day one post P. aeruginosa infec-
tion, a high decrease of body weight associated to low
mortality rate was reported [17, 22]. Based on the statistical
significance, using Bonferroni’s Multiple Comparison Tests
(reported in Additional file 3), CC lines were arranged in
three groups for MTS and CBW1 by increasing order of
magnitude, as described [24].
Estimation of heritability
Broad sense heritability - including epistatic but not domin-
ance effects for MST and CBW1 - was calculated across the
CC lines under P. aeruginosa infection and in naïve condi-
tions as described [23]. Briefly, One-way ANOVA by CC
line was implemented separately for MST and CBW1.
Based on these analyses, broad sense heritability (H2), was
calculated across the CC lines under control and challenge
conditions, separately.
Statistical analysis
Spearman‘s correlation was used for associations tests.
One- and Two-ANOVA and Bonferroni’s Multiple Com-
parison Tests were used to determine the statistical
significance, using GraphPad software.
Additional files
Additional file 1: Table S1. Survival Time of each CC lines after P.
aeruginosa airway infection. (DOCX 51 kb)
Additional file 2: Table S2. Change in body weight of each CC line
after P. aeruginosa airway. (DOCX 51 kb)
Additional file 3: Table S3. Bonferroni’s Multiple Comparison Tests of
recorded traits (MST and CBW1) among CC lines after P. aeruginosa
airway infection. (DOCX 74 kb)
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